Delivery Order SPE2DB24D8003-SPE2DB24FJTGR

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,311.87, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC,...
The U.S. Defense Logistics Agency (DLA) awarded a $6,399.12 firm-fixed-price delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 4566343564 units of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical product. This delivery order falls under Dakota Drug's existing indefinite delivery contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which supports the DLA Troop Support Medical's ECAT Generation V Program. The contract has an ultimate completion date...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $5,846.07, is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a prescription medication. The contract is a firm fixed-price, non-set-aside delivery order with a performance period ending on February 26, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The order, valued at $4,062.92, is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a respiratory medication. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, which allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a $2,578.55 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. This delivery order contract is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S prescription medication. The $5,011.42 firm fixed-price contract has a period of performance through November 8, 2024 and is not designated as a set-aside. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which enables...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a potential value of $7,580.61 and a completion date of January 18, 2024. This delivery order is issued against Dakota Drug, Inc.'s existing blanket purchase agreement...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $5,368.53 contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has a performance period ending on March 14, 2024 and does not include a set-aside designation. Through this and previous awards, Dakota Drug has provided a wide range of medical supplies and...
This is a firm fixed-price delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,010.46 and is for the delivery of Trelegy Ellipta 200-62.5-25 60S, a pharmaceutical product used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of April 23, 2024 and was awarded on April 22, 2024 without...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,693.07, is for the procurement of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The delivery order does not have a set-aside designation and supports the DLA Troop Support Medical's mission of providing comprehensive medical supply chain operations for the U.S. Armed...
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB24FJTGR
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of TRELEGY ELLIPTA 100-62.5-25 60S, a prescription medication used to treat conditions such as asthma and COPD. The contract, valued at $2,073.87, has an ultimate completion date of August 13, 2024 and does not have a set-aside designation.

Dakota Drug, Inc. is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows the company to supply a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This delivery order is part of the company's broader contractual relationship with the DLA to provide critical medical items to military treatment facilities.

Generated 11/11/24, 9:08 AM